Hepatocellular Carcinoma

Shirato, Kazuhito; Morimoto, Manabu; Tomita, Naohide; Kokawa, Atsushi; Sugimori, Kazuya; Saito, Toshifumi; Numata, Kazushi; Sekihara, Hisahiko; Tanaka, Katsuaki

doi:10.7863/jum.2002.21.9.1015

Cited by 4 publications

(1 citation statement)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…An attempt to use Doppler CEUS for guiding percutaneous ablation of HCC was reported only in one study whereby 20 patients were treated with PEI after transarterial infusion of chemotherapy for 23 HCC [19]. Each of the lesions was hypervascular at color Doppler CEUS before PEI.…”

Section: Targeting Hccmentioning

confidence: 99%

Contrast-Enhanced Ultrasound Techniques for Guiding and Assessing Response to Locoregional Treatments for Hepatocellular Carcinoma

Andreana

Kudo²,

Hatanaka³

et al. 2010

Oncology

View full text Add to dashboard Cite

Most hepatocellular carcinomas (HCC) are diagnosed in patients with cirrhosis and/or when tumor burden is too advanced for surgical treatment. In many of these cases the only suitable therapy is locoregional, percutaneous and/or intraarterial treatment. Moreover, the best way to guide and assess response to locoregional HCC treatment are two issues under discussion today. First-generation and subsequent second-generation microbubble contrast agents, together with contrast-enhanced ultrasound (US) imaging, have expanded the role of US techniques in HCC treatments. In this review our purpose is to illustrate the advantages, limits and potential of contrast-enhanced US application for locoregional HCC treatment.

show abstract

Section: Targeting Hccmentioning

confidence: 99%